用于特定细菌显像的SPECT放射性药物现状
该综述聚焦用于细菌特异性SPECT显像的放射性标记抗生素,阐述其作用机制、临床前研究中的潜力与局限。多数有前景的方法仍停留在实验室阶段,尚待解决关键问题才能转化至临床实践。
要点
- 核医学可鉴别感染与炎症,但特异性靶向病原体仍是未满足的临床需求。
- 放射性标记抗生素SPECT显像在临床前研究中显示出潜力。
- 多数方法仍处于实验室阶段,转化至临床前尚需解决关键问题。
核心结论
- 多种细菌特异性显像方法在临床前研究中提供了有前景的视角,但大多数方法仍局限于实验室阶段,转化至临床实践前仍需解决关键问题。
研究设计与样本
- 该综述聚焦用于细菌SPECT显像的放射性标记抗生素,涵盖其作用机制、潜力及床旁应用的局限性。
主要发现
- 核医学可区分感染与炎症,但缺乏特异性靶向致病病原体的策略。
- 微生物学或组织学诊断常依赖有创操作,易受污染或采样偏倚影响,且不能反映感染过程的空间异质性。
- 放射性标记抗生素SPECT显像在临床前研究中显示出潜力,但多数方法仍停留在实验室阶段。
局限性
- 多数有前景的细菌特异性显像方法仍局限于实验室阶段,转化至临床实践前仍需解决关键问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Imaging infection still represents a challenge for researchers. Despite nuclear medicine (NM) offers valuable tools able to discriminate between infections and inflammation, there is an unmet clinical need to develop new strategies able to specifically target the causative pathogen, to select the best antimicrobial treatment for each patient and to accurately assess therapeutic efficacy. These aspects are commonly addressed by microbiology or histology but the diagnosis often relies on invasive procedures that are prone to contamination or sample bias and do not reflect the spatial heterogeneity of the infective process. Therefore, in the era of personalized medicine and treatment, a lot of efforts are in play to improve a personalized diagnosis. Molecular imaging is an ideal candidate for this purpose and, indeed, research is going fast to this direction aiming to find more selective and proper antimicrobial treatments and to overcome broad-spectrum antibiotic use, which still represents the major cause of bacterial drug-resistance. Several approaches for specifically image bacteria have been proposed and provided encouraging perspectives in preclinical studies. Nevertheless, the majority of these promising approaches are still confined in "bench stages" and crucial issues still need to be addressed before their translation in clinical practice. This review will focus on radiolabeled antibiotics for SPECT imaging of bacteria, their mechanisms of action, their potentiality and limitations for "bed-side" applications.
引用
- Signore A, Bentivoglio V, Varani M, et al. Current Status of SPECT Radiopharmaceuticals for Specific Bacteria Imaging. Semin Nucl Med. 2023. PMID: 36609002. doi:10.1053/j.semnuclmed.2022.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。